Video yükleniyor...

Video Yüklenemedi

Bu video yüklenirken bir sorun oluştu. Bu geçici bir ağ sorunundan kaynaklanıyor olabilir veya video kullanılamıyor olabilir.

Ana Sayfaya Dön

So gratifying to see long-term memory in an aggressive tumor such as triple negative breast cancer. We see this result of long duration in pancreatic, bladder & lung cancer, confirming that maintaining ALC as an adjunct to modified current therapy results in long-term remission

Dr. Pat Soon-Shiong

155,336 subscribers

51,864 görüntüleme • 7 ay önce •via X (Twitter)

Sağlık & İyilik Bilim & Teknoloji

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

Exciting results in lung cancer today. It is my belief that treating lymphopenia in patients with low NK and T cell count, is as essential as treating anemia (low red blood cells count) or neutropenia (low neutrophil count) which occurs as a consequence of chemotherapy, independent of tumor types. This will herald in the paradigm change of treating the immune system itself and allow the immune system to cure the cancer, regardless of its anatomical location. The long-term survival in patients with bladder cancer and now in lung cancer provide evidence of the potential validity of this hypothesis, with ANKTVIA as the foundation of the Bioshield platform.

Exciting results in lung cancer today. It is my belief that treating lymphopenia in patients with low NK and T cell count, is as essential as treating anemia (low red blood cells count) or neutropenia (low neutrophil count) which occurs as a consequence of chemotherapy, independent of tumor types. This will herald in the paradigm change of treating the immune system itself and allow the immune system to cure the cancer, regardless of its anatomical location. The long-term survival in patients with bladder cancer and now in lung cancer provide evidence of the potential validity of this hypothesis, with ANKTVIA as the foundation of the Bioshield platform.

Dr. Pat Soon-Shiong

43,436 görüntüleme • 10 ay önce

Today, we join with other cancer charities in calling on all political parties to commit to publishing a long-term cancer strategy for England to improve cancer outcomes. People affected by cancer need a plan #OneCancerVoice

Today, we join with other cancer charities in calling on all political parties to commit to publishing a long-term cancer strategy for England to improve cancer outcomes. People affected by cancer need a plan #OneCancerVoice

Cancer Research UK

26,268 görüntüleme • 2 yıl önce

Launched this 20 yrs ago on #albumin and #Abraxane to educate oncologists about feeding the tumor in breast, lung & pancreatic #cancer. Frustrating it takes 20 yrs to recognize the impact of the biology of our body. Feed the tumor, don't starve it. Save your #immunesystems.

Launched this 20 yrs ago on #albumin and #Abraxane to educate oncologists about feeding the tumor in breast, lung & pancreatic #cancer. Frustrating it takes 20 yrs to recognize the impact of the biology of our body. Feed the tumor, don't starve it. Save your #immunesystems.

Dr. Pat Soon-Shiong

30,642 görüntüleme • 1 yıl önce

We discovered that mRNA technology induces long-term genetic damage and biochemical HAVOC — turning THOUSANDS of genes off/on in ways that fuel cancer, clotting, inflammation, mitochondrial failure & immune collapse. Accountability for this global crime is LONG overdue.

We discovered that mRNA technology induces long-term genetic damage and biochemical HAVOC — turning THOUSANDS of genes off/on in ways that fuel cancer, clotting, inflammation, mitochondrial failure & immune collapse. Accountability for this global crime is LONG overdue.

Nicolas Hulscher, MPH

40,444 görüntüleme • 4 ay önce

We discovered that mRNA technology induces long-term genetic damage and biochemical HAVOC — turning THOUSANDS of genes on/off in ways that fuel cancer, clotting, inflammation, mitochondrial failure & immune dysfunction. Accountability for this global crime is long overdue.

We discovered that mRNA technology induces long-term genetic damage and biochemical HAVOC — turning THOUSANDS of genes on/off in ways that fuel cancer, clotting, inflammation, mitochondrial failure & immune dysfunction. Accountability for this global crime is long overdue.

Nicolas Hulscher, MPH

96,978 görüntüleme • 6 ay önce

Piers Morgan: "I was with one of the top cancer experts in Britain for lunch a couple of days ago, who was utterly scathing about the long-term impact of the mRNA vaccines ... and says that they're reaping a whirlwind in the world of cancer as a result of the vaccines."

Piers Morgan: "I was with one of the top cancer experts in Britain for lunch a couple of days ago, who was utterly scathing about the long-term impact of the mRNA vaccines ... and says that they're reaping a whirlwind in the world of cancer as a result of the vaccines."

James Melville 🚜

16,589 görüntüleme • 1 yıl önce

🚨 PIERS MORGAN: "I was with one of the top cancer experts in Britain for lunch a couple of days ago, who was utterly scathing about the long-term impact of the mRNA vaccines ... and says that they're reaping a whirlwind in the world of cancer as a result of the vaccines."

🚨 PIERS MORGAN: "I was with one of the top cancer experts in Britain for lunch a couple of days ago, who was utterly scathing about the long-term impact of the mRNA vaccines ... and says that they're reaping a whirlwind in the world of cancer as a result of the vaccines."

Chief Nerd

3,705,476 görüntüleme • 1 yıl önce

🔸️"You Gotta Think Long Term"🔸️ 🔸️"We as Citizens of the World can't trust our Governments to Manage Monetary Supply in a Long Term Responsible Way, there's a lot of evidence to support that statement"🔸️ Brad Garlinghouse

🔸️"You Gotta Think Long Term"🔸️ 🔸️"We as Citizens of the World can't trust our Governments to Manage Monetary Supply in a Long Term Responsible Way, there's a lot of evidence to support that statement"🔸️ Brad Garlinghouse

Boncryp Digital Asset Advocate

34,529 görüntüleme • 1 yıl önce

"NEW STUDY: Fenbendazole Linked to Remission or Near-Remission in Three Stage IV Cancer Patients Breast, prostate, and melanoma patients experienced dramatic tumor regression and long-lasting remission — without chemotherapy." Nicolas Hulscher MPH Nicolas Hulscher, MPH McCullough Foundation Peter A. McCullough, MD, MPH® full article below

"NEW STUDY: Fenbendazole Linked to Remission or Near-Remission in Three Stage IV Cancer Patients Breast, prostate, and melanoma patients experienced dramatic tumor regression and long-lasting remission — without chemotherapy." Nicolas Hulscher MPH Nicolas Hulscher, MPH McCullough Foundation Peter A. McCullough, MD, MPH® full article below

DoctorRay

17,466 görüntüleme • 10 ay önce

Rutte is trying to back down. - In the communiqué, you described Russia as a long-term threat. Isn't Putin an immediate threat? Did you soften the wording to reach an agreement? - No. Of course, if someone is a long-term threat, they are also a threat in the short term. So they are a threat now and a threat in the future. - sk

Rutte is trying to back down. - In the communiqué, you described Russia as a long-term threat. Isn't Putin an immediate threat? Did you soften the wording to reach an agreement? - No. Of course, if someone is a long-term threat, they are also a threat in the short term. So they are a threat now and a threat in the future. - sk

Zlatti71

19,196 görüntüleme • 1 yıl önce

Melbourne residents keep voting for this incompetent gov’t waiting to see different results. As long as they are in power we will be living with this nightmare.

Melbourne residents keep voting for this incompetent gov’t waiting to see different results. As long as they are in power we will be living with this nightmare.

katy 🌸

19,161 görüntüleme • 1 yıl önce

The recent breakthrough in pancreatic cancer therapy isn't a cure. But it *may be* a pathway to one. Pancreatic cancer has miserable survival rates. Most cases are driven by RAS, a protein long considered basically undruggable. Revolution Medicines found a way to target RAS with daraxonrasib, which nearly doubled median overall survival versus chemo, and was easier to tolerate. Crucially, being able to target RAS gives pancreatic cancer therapy a new foundation. Other drugs can be layered on top of daraxonrasib to even better results than the drug alone. Samuel Hume explains:

The recent breakthrough in pancreatic cancer therapy isn't a cure. But it may be a pathway to one. Pancreatic cancer has miserable survival rates. Most cases are driven by RAS, a protein long considered basically undruggable. Revolution Medicines found a way to target RAS with daraxonrasib, which nearly doubled median overall survival versus chemo, and was easier to tolerate. Crucially, being able to target RAS gives pancreatic cancer therapy a new foundation. Other drugs can be layered on top of daraxonrasib to even better results than the drug alone. Samuel Hume explains:

TBPN

62,355 görüntüleme • 1 ay önce

I think it’s time for Congress to reassert itself. We owe that to those that we represent, as well as to this institution, for the long-term good of the nation.

I think it’s time for Congress to reassert itself. We owe that to those that we represent, as well as to this institution, for the long-term good of the nation.

Sen. Lisa Murkowski

93,444 görüntüleme • 1 yıl önce

🇺🇸🇺🇦 Elections in Ukraine will take place when all Ukrainians can vote, all of them. - Blinken So as long as Russia holds territories, there will not be an election, even if there is a long term ceasefire or peace.

🇺🇸🇺🇦 Elections in Ukraine will take place when all Ukrainians can vote, all of them. - Blinken So as long as Russia holds territories, there will not be an election, even if there is a long term ceasefire or peace.

Lord Bebo

2,563,724 görüntüleme • 2 yıl önce

The truth about breast-feeding and breast cancer Is it true that 1 in 20 breast cancers could be prevented by breast feeding? This was a statement lifted from the Lancet Breast Cancer Commission Report published yesterday - but it’s a global estimate that assumes EVERY woman in EVERY country has an average of 6 children and breastfeeds them for 1-2 years. The facts - breastfeeding one child for 12 months reduces your lifetime risk of breast cancer by 4% That’s a drop from 17% to 16.4% - so the actual impact is small. The Report wants to increase breast-feeding education and support globally as en masse this will reduce the numbers of breast cancer - but you don’t need to feel guilty if you didn’t breastfeed for that long or didn’t have children If you want to find out your own individual risk of breast cancer, check out the iPrevent tool - Thanks to Wanda (Wanyuan) Cui The Lancet Breast Cancer Now

The truth about breast-feeding and breast cancer Is it true that 1 in 20 breast cancers could be prevented by breast feeding? This was a statement lifted from the Lancet Breast Cancer Commission Report published yesterday - but it’s a global estimate that assumes EVERY woman in EVERY country has an average of 6 children and breastfeeds them for 1-2 years. The facts - breastfeeding one child for 12 months reduces your lifetime risk of breast cancer by 4% That’s a drop from 17% to 16.4% - so the actual impact is small. The Report wants to increase breast-feeding education and support globally as en masse this will reduce the numbers of breast cancer - but you don’t need to feel guilty if you didn’t breastfeed for that long or didn’t have children If you want to find out your own individual risk of breast cancer, check out the iPrevent tool - Thanks to Wanda (Wanyuan) Cui The Lancet Breast Cancer Now

Dr Liz O'Riordan

45,065 görüntüleme • 2 yıl önce

The derailment of a train carrying toxic chemicals linked to cancer has raised concerns in the US of long-term health risks for the residents of East Palestine, Ohio ⤵️

The derailment of a train carrying toxic chemicals linked to cancer has raised concerns in the US of long-term health risks for the residents of East Palestine, Ohio ⤵️

Al Jazeera English

282,446 görüntüleme • 3 yıl önce

New reporting from City Reporter shows Black unemployment in NYC is nearly 9%. As a lifelong New Yorker and emergency physician, I see this as more than an economic issue. Employment shapes housing, food security, stress, access to care, and long-term health.

New reporting from City Reporter shows Black unemployment in NYC is nearly 9%. As a lifelong New Yorker and emergency physician, I see this as more than an economic issue. Employment shapes housing, food security, stress, access to care, and long-term health.

uché blackstock, md

14,141 görüntüleme • 7 gün önce

🚨IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION Based on Dr. William Makis MD's commonly shared dosing framework Thousands of people reference this ivermectin dosing chart. Below is a simplified breakdown organized by body weight (mg/kg per day). 📌LOW DOSE ≤ 0.5 mg/kg/day Best For: • Cancers in remission • Strong family history or genetic predisposition • Preventive (prophylactic) use Reported Side Effects: • No long-term side effects reported Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer patient who received chemotherapy plus 12 mg ivermectin daily. After 2 months, the tumor marker CA125 fell from 288 to 22, and the tumor was reported to have disappeared. 📌MEDIUM DOSE 1.0 mg/kg/day Best For: • Starting dose for many cancers including: • Lung cancer • Pancreatic cancer • Renal cell carcinoma • Gastric cancer Reported Side Effects: • No long-term side effects reported Example: Dr. Shankara Chetty reported a 70-year-old prostate cancer patient with a PSA of 89 taking 45 mg daily (along with lactoferrin). After 2 months, PSA reportedly decreased to 10.9. 📌HIGH DOSE 2.0 mg/kg/day Best For: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers Reported Side Effects: • No long-term side effects reported Example: Dr. Allan Landrito reported a Stage 4 gallbladder cancer patient taking 2 mg/kg daily for 14 months, with the cancer reportedly disappearing. 📌VERY HIGH DOSE ≥ 2.5 mg/kg/day Best For: • Extensive metastatic disease • Extremely poor prognosis • Certain aggressive brain cancers Possible Side Effects: • Temporary visual disturbances • Usually, short lived and resolve within days Example: Dr. Shankara Chetty reported using 2.5 mg/kg/day in a patient with no side effects reported. #Ivermectin #MakisMD #Genixmeds

🚨IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION Based on Dr. William Makis MD's commonly shared dosing framework Thousands of people reference this ivermectin dosing chart. Below is a simplified breakdown organized by body weight (mg/kg per day). 📌LOW DOSE ≤ 0.5 mg/kg/day Best For: • Cancers in remission • Strong family history or genetic predisposition • Preventive (prophylactic) use Reported Side Effects: • No long-term side effects reported Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer patient who received chemotherapy plus 12 mg ivermectin daily. After 2 months, the tumor marker CA125 fell from 288 to 22, and the tumor was reported to have disappeared. 📌MEDIUM DOSE 1.0 mg/kg/day Best For: • Starting dose for many cancers including: • Lung cancer • Pancreatic cancer • Renal cell carcinoma • Gastric cancer Reported Side Effects: • No long-term side effects reported Example: Dr. Shankara Chetty reported a 70-year-old prostate cancer patient with a PSA of 89 taking 45 mg daily (along with lactoferrin). After 2 months, PSA reportedly decreased to 10.9. 📌HIGH DOSE 2.0 mg/kg/day Best For: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers Reported Side Effects: • No long-term side effects reported Example: Dr. Allan Landrito reported a Stage 4 gallbladder cancer patient taking 2 mg/kg daily for 14 months, with the cancer reportedly disappearing. 📌VERY HIGH DOSE ≥ 2.5 mg/kg/day Best For: • Extensive metastatic disease • Extremely poor prognosis • Certain aggressive brain cancers Possible Side Effects: • Temporary visual disturbances • Usually, short lived and resolve within days Example: Dr. Shankara Chetty reported using 2.5 mg/kg/day in a patient with no side effects reported. #Ivermectin #MakisMD #Genixmeds

GENIX MEDS

31,014 görüntüleme • 1 ay önce

🚨Dr. William Makis: Ivermectin Dosing for Cancer Explained In one of his recent talks, Dr. William Makis shared what he considers the most important dosing guide for using Ivermectin in cancer. According to Dr. Makis, the starting dose for most cancers is 1 mg per kilogram of body weight per day For example, a person weighing 60 kg would take 60 mg daily, that’s five 12 mg pills or roughly one teaspoon (6 ml) of liquid ivermectin. He mentioned that Ivermectin has shown positive effects in many types of cancer, including: - Breast cancer - Colon cancer - Lung cancer - Pancreatic cancer - Gastric cancer - Renal cell carcinoma - Leukemias He noted that there is very little research on lymphomas, but that doesn’t mean it won’t work, it simply hasn’t been studied much yet. Important points from Dr. Makis: 1) The anti-cancer effect of Ivermectin appears to be dose dependent. 2) Higher doses may offer better results in more aggressive cancers. 3) For very aggressive cancers (such as pancreatic, leukemia, or brain cancers), he suggests considering 2 mg/kg or even up to 2.5 mg/kg per day. Some patients have used these higher doses for many months with only temporary side effects (such as mild visual disturbances that usually resolve within a few days). Real-world examples include a prostate cancer patient whose PSA dropped from 89 to 11 on 45 mg daily, and a terminal gallbladder cancer case that resolved after 14 months on 2 mg/kg. Dr. Makis emphasizes that Ivermectin is a very safe drug with no reported long-term side effects at 1 mg/kg. He recommends starting at this dose and adjusting upwards depending on the individual case and cancer type. He also stresses that people can safely stay on Ivermectin for months as long as there is active disease. If you're researching Ivermectin for cancer protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade Ivermectin with straightforward worldwide delivery. #Ivermectindosage #MakisMD #Genixmeds

🚨Dr. William Makis: Ivermectin Dosing for Cancer Explained In one of his recent talks, Dr. William Makis shared what he considers the most important dosing guide for using Ivermectin in cancer. According to Dr. Makis, the starting dose for most cancers is 1 mg per kilogram of body weight per day For example, a person weighing 60 kg would take 60 mg daily, that’s five 12 mg pills or roughly one teaspoon (6 ml) of liquid ivermectin. He mentioned that Ivermectin has shown positive effects in many types of cancer, including: - Breast cancer - Colon cancer - Lung cancer - Pancreatic cancer - Gastric cancer - Renal cell carcinoma - Leukemias He noted that there is very little research on lymphomas, but that doesn’t mean it won’t work, it simply hasn’t been studied much yet. Important points from Dr. Makis: 1) The anti-cancer effect of Ivermectin appears to be dose dependent. 2) Higher doses may offer better results in more aggressive cancers. 3) For very aggressive cancers (such as pancreatic, leukemia, or brain cancers), he suggests considering 2 mg/kg or even up to 2.5 mg/kg per day. Some patients have used these higher doses for many months with only temporary side effects (such as mild visual disturbances that usually resolve within a few days). Real-world examples include a prostate cancer patient whose PSA dropped from 89 to 11 on 45 mg daily, and a terminal gallbladder cancer case that resolved after 14 months on 2 mg/kg. Dr. Makis emphasizes that Ivermectin is a very safe drug with no reported long-term side effects at 1 mg/kg. He recommends starting at this dose and adjusting upwards depending on the individual case and cancer type. He also stresses that people can safely stay on Ivermectin for months as long as there is active disease. If you're researching Ivermectin for cancer protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade Ivermectin with straightforward worldwide delivery. #Ivermectindosage #MakisMD #Genixmeds

GENIX MEDS

19,733 görüntüleme • 27 gün önce